...
首页> 外文期刊>Journal of Clinical Microbiology >Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease
【24h】

Severity-Related Changes of Bronchial Microbiome in Chronic Obstructive Pulmonary Disease

机译:慢性阻塞性肺疾病中支气管微生物组的严重程度相关变化

获取原文
           

摘要

Bronchial colonization by potentially pathogenic microorganisms (PPMs) is often demonstrated in chronic obstructive pulmonary disease (COPD), but culture-based techniques identify only a portion of the bacteria in mucosal surfaces. The aim of the study was to determine changes in the bronchial microbiome of COPD associated with the severity of the disease. The bronchial microbiome of COPD patients was analyzed by 16S rRNA gene amplification and pyrosequencing in sputum samples obtained during stable disease. Seventeen COPD patients were studied (forced expiratory volume in the first second expressed as a percentage of the forced vital capacity [FEV1%] median, 35.0%; interquartile range [IQR], 31.5 to 52.0), providing a mean of 4,493 (standard deviation [SD], 2,598) sequences corresponding to 47 operational taxonomic units (OTUs) (SD, 17) at a 97% identity level. Patients were dichotomized according to their lung function as moderate to severe when their FEV1% values were over the median and as advanced when FEV1% values were lower. The most prevalent phyla in sputum were Proteobacteria (44%) and Firmicutes (16%), followed by Actinobacteria (13%). A greater microbial diversity was found in patients with moderate-to-severe disease, and alpha diversity showed a statistically significant decrease in patients with advanced disease when assessed by Shannon (ρ = 0.528; P = 0.029, Spearman correlation coefficient) and Chao1 (ρ = 0.53; P = 0.028, Spearman correlation coefficient) alpha-diversity indexes. The higher severity that characterizes advanced COPD is paralleled by a decrease in the diversity of the bronchial microbiome, with a loss of part of the resident flora that is replaced by a more restricted microbiota that includes PPMs.
机译:在慢性阻塞性肺疾病(COPD)中经常显示出潜在致病性微生物(PPM)引起的支气管定植,但是基于培养的技术仅能识别粘膜表面的一部分细菌。该研究的目的是确定与疾病严重程度相关的COPD支气管微生物组的变化。通过在稳定疾病期间获得的痰液样本中的16S rRNA基因扩增和焦磷酸测序分析COPD患者的支气管微生物组。研究了17名COPD患者(第一秒钟的强制呼气量以强制肺活量[FEV 1 %]中位数的百分比表示,为35.0%;四分位间距[IQR]为31.5至52.0),以97%的同一性水平提供了对应于47个操作分类单位(OTU)(SD,17)的平均4,493个(标准差[SD],2,598个)序列。当患者的FEV 1 %值超过中位数时,根据肺功能将患者分为中度至重度,而当FEV 1 %值降低时,患者则分为晚期。痰中最普遍的门菌是Proteobacteria(44%)和Firmicutes(16%),其次是Actinobacteria(13%)。用Shannon评估,中重度疾病患者的微生物多样性更高,晚期疾病患者的α多样性显示统计学上的显着降低(ρ= 0.528; P = 0.029,Spearman相关系数)和Chao1(ρ= 0.53; P = 0.028,Spearman相关系数)α-多样性指数。表现为晚期COPD的更高的严重性与支气管微生物组多样性的降低并存,一部分常驻菌群的丧失被包括PPM的更严格的微生物群所取代。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号